Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Clinical Outcomes and Healthcare Utilization in Patients with Sickle Cell Disease: A Nationwide Cohort Study of Medicaid Beneficiaries

Rishi J Desai, MS, PhD, Mufaddal Mahesri, MD MPH, Raisa Levin, Denise Globe, PhD, Krista McKerracher, MBA, Alex Mutebi, PhD, Rhonda Bohn, ScD, Maureen Achebe, MD MPH, Sebastian Schneeweiss, MD ScD

Blood (2019) 134 (Supplement_1): 3459.

https://doi.org/10.1182/blood-2019-130373

Published: 2019

Journal Articles

Incidence and Survival of Multiple Myeloma; A Population-Based Study on 10 961 Patients Diagnosed 1982-2017

Øystein Langseth, MD, Tor Åge Myklebust, M.sc, PhD, Tom Børge Johannesen, MD PhD, Øyvind Hjertner, MD PhD, Anders Waage, MD PhD

Blood (2019) 134 (Supplement_1): 4380.

https://doi.org/10.1182/blood-2019-129816

Published: 2019

Journal Articles

The Impact of Age on the Outcome of Primary Treatment for Classical Hodgkin's Lymphoma: 70 Years of Age Is a Clinical Relevant Cutpoint and the Most Important Predictor of Overall Survival

Lourdes Calvente, MD, Manjula Maganti, MSc, Mary Gospodarowicz, MD FRCPC, David C. Hodgson, MD MPH, FRCPC, Danielle Rodin, MD MPH, FRCPC, Alexander Sun, MD FRCPC, Richard Tsang, MD FRCPC, Robert Kridel, MDMPH,PhD, Vishal Kukreti, MD, Anca Prica, MD, Michael Crump, MD FRCPC, John Kuruvilla, MD

Blood (2019) 134 (Supplement_1): 1559.

https://doi.org/10.1182/blood-2019-130282

Published: 2019

Journal Articles

The Conundrum of Hydroxyurea Use and Health Care Utilization in Sickle Cell Disease

Akshaya Arjunan, BS, Deborah Moss, MD MPH, Sydna B. Burns, Laura M. De Castro, MD

Blood (2018) 132 (Supplement 1): 2282.

https://doi.org/10.1182/blood-2018-99-117735

Published: 2018

Journal Articles

Analysis of Genetic Abnormalities in Newly Diagnosed Acute Lymphoblastic Leukemia Patients at King Faisal Specialist Hospital & Research Centre

Osamah Khojah, MD, Mohammed Almajed, MD, Shahad Fareed Barri, MD, Ahmed Alfaran, MD, Mohammed Alsharif, MD, Nasser Alsaif, MD, Abdulaziz Alrajeh, MD, Suleimman Al-Sweedan, MD, Salem Khalil, MB, BS, FRCPA, FCAP

Blood (2018) 132 (Supplement 1): 5289.

https://doi.org/10.1182/blood-2018-99-117673

Published: 2018

Journal Articles

Opioid Use Is NOT Associated with in-Hospital Mortality Among Patients with Sickle CELL Disease in the United States: Findings from the National Inpatient Sample

Oladimeji Akinola Akinboro, MBBS, Stanley Nwabudike, MD, Camille Edwards, MD, Diana Cirstea, MD, Nana Oduraa Addo-Tabiri, MD PhD, Michael Voisine, MD, Hassan Yameen, MD, Adetola A. Kassim, MD MS

Blood (2018) 132 (Supplement 1): 315.

https://doi.org/10.1182/blood-2018-99-115573

Published: 2018

Journal Articles

Patient-Reported Disease Burden in the Elderly Patients with Acute Myeloid Leukemia

Renee Pierson, MBA, Jianming He, PhD, Liang Xiu, PhD, Sepideh Nemat, MD PhD, Christina Loefgren, MD PhD, Xavier Thomas, MD

Blood (2017) 130 (Supplement 1): 2182.

https://doi.org/10.1182/blood.V130.Suppl_1.2182.2182

Published: 2017

Journal Articles

Factors Predicting Poor Outcomes for Myeloma Patients at Different Ages: Results from 3894 Patients in the Myeloma XI Trial

Charlotte Pawlyn, BA,PhDMBBChir,MRCP,FRCPath, Martin F Kaiser, MD, David Cairns, BSc, MSc, PhD, Alina Striha, MSc, John R Jones, MD, Vallari Shah, MBBS, Matthew W Jenner, Mark T Drayson, MD PhD, Roger G Owen, MD, Walter M Gregory, PhD, Gordon Cook, MD PhD, Graham Jackson, MDPhD, Gareth J. Morgan, MD PhD, Faith E Davies, MD

Blood (2017) 130 (Supplement 1): 3040.

https://doi.org/10.1182/blood.V130.Suppl_1.3040.3040

Published: 2017

Journal Articles

Persistent Racial/Ethnic Disparities in Outcomes for Multiple Myeloma: A SEER-Database Update

Kevin R. Kelly, MD PhD, Dongyun Yang, Mayank Sharma, MBBS, Vivek Roy, MD, Asher A. Chanan-Khan, MD, Sikander Ailawadhi, MD

Blood (2016) 128 (22): 1191.

https://doi.org/10.1182/blood.V128.22.1191.1191

Published: 2016

Journal Articles

Social Outcomes after High Dose Chemotherapy with Autologous Stem Cell Transplant

Bente Arboe, Jette Soenderskov Goerloev, MD, Maja Halgren Olsen, Susanne Oksbjerg Dalton, Kristina Fruerlund Nielsen, Soeren Ramme Nielsen, Charlotte Madsen, MD, Rasmus Nielsen, Peter de Nully Brown, MD PhD

Blood (2016) 128 (22): 1193.

https://doi.org/10.1182/blood.V128.22.1193.1193

Published: 2016

Journal Articles

Timing of Initiation of Defibrotide Post-Diagnosis of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Post-Hematopoietic Stem Cell Transplantation: Exploratory Age-Group Analysis from an Expanded Access Study

Stephan A. Grupp, MD PhD, Angela R. Smith, MD, Brandon M. Triplett, MD, Nancy A. Kernan, MD, Joseph H. Antin, MD, Leslie Lehmann, MD, Wei Liang, PhD, Robin Hume, MS, William Tappe, MD, Paul G. Richardson, MD

Blood (2016) 128 (22): 66.

https://doi.org/10.1182/blood.V128.22.66.66

Published: 2016

Journal Articles

Presentation and Time to Treatment of Atypical Hemolytic Uremic Syndrome Is Influenced By Complement Amplifying Conditions: A Single Center Experience

Julia M Cunningham, MD, Jimmy Wang, PhD, Catherine Broome, MD

Blood (2016) 128 (22): 2543.

https://doi.org/10.1182/blood.V128.22.2543.2543

Published: 2016

Journal Articles

Mini-Chromosome Maintenance (MCM) DNA Helicase Genes Influence Acute Myeloid Leukemia (AML) Replication and Response to Chemotherapy-Induced DNA Damage

Joe Chin-Sun Huang, MD, Julia Sidorova, PhD, Sylvia Chien, Jin Dai, Ben Logsdon, PhD, Su-In Lee, PhD, Raymond J Monnat, MD, Pamela S. Becker, MD PhD

Blood (2015) 126 (23): 3629.

https://doi.org/10.1182/blood.V126.23.3629.3629

Published: 2015

Journal Articles

Safety of Peripheral Hematopoietic Stem Cell Mobilization with Lenograstim in Allogeneic Healthy Donors ≥ 50 Years Old: A Single-Centre Experience

Massimo Martino, MD, Antonella Dattola, Roberta Fedele, MD, Antonella Pontari, Tiziana Moscato, MD, Maria Cuzzola, Tiziana Martinello

Blood (2014) 124 (21): 3844.

https://doi.org/10.1182/blood.V124.21.3844.3844

Published: 2014

Journal Articles

Age Related Outcomes for Multiple Myeloma Patients Following Autologous Transplantation

Justin LaPorte, PharmD, BCOP, Stacey Brown, B.A., Xu Zhang, PhD, Asad Bashey, MD PhD, Lawrence E. Morris, MD, H. Kent Holland, MD, Scott R. Solomon, MD

Blood (2014) 124 (21): 3968.

https://doi.org/10.1182/blood.V124.21.3968.3968

Published: 2014

Journal Articles

Influence Of Age On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis Of RE-Cover and RE-Cover II

Sam Schulman, MD, PhD, Henry Eriksson, MD, PhD, Samuel Z Goldhaber, MD, Ajay Kakkar, MB, BS, PhD, Clive Kearon, MB, PhD, Sebastian M Schellong, MD, Joerg Kreuzer, MD, Nuala Peter, BSc (Hons), Jeffrey Friedman, MD

Blood (2013) 122 (21): 2375.

https://doi.org/10.1182/blood.V122.21.2375.2375

Published: 2013

Journal Articles

Initial Characteristics, Treatment and Prognosis Of Elderly (≥ 70 years) Patients With Chronic Lymphocytic Leukemia (CLL): An Analysis Of a Series Of 367 Cases

Tycho Baumann, MD, Julio Delgado, MD, PhD, Rodrigo Santacruz, MD, Alejandra Martínez-Trillos, MD, Cristina Royo, PhD, Alba Navarro, PhD, Magdalena Pinyol, PhD, María Rozman, MD, PhD, Cristina López, PhD, Neus Villamor, MD, PhD, Marta Aymerich, MD, PhD, Arturo Pereira, MD, PhD, Anna Carrió, PhD, Emili Montserrat, MD, PhD

Blood (2013) 122 (21): 4155.

https://doi.org/10.1182/blood.V122.21.4155.4155

Published: 2013

Journal Articles

Phase II Clinical and Correlative Study Of Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Extended Dosing (CRD-R) Induces High Rates Of MRD Negativity In Newly Diagnosed Multiple Myeloma (MM) Patients

Blood (2013) 122 (21): 538.

https://doi.org/10.1182/blood.V122.21.538.538

Published: 2013

Journal Articles

Survival Improvements Following Myeloablative Allogeneic Hematopoietic Cell Transplantation For Acute Lymphoblastic Leukemia In Adolescents and Young Adults Have Been Comparable To Younger Children: A Study From The Cibmtr

William A. Wood, MD, MPH, Stephanie J. Lee, MD, MPH, Ruta Brazauskas, PhD, Zhiwei Wang, MS, Mahmoud D. Aljurf, MD, Karen K. Ballen, MD, David K. Buchbinder, MD, MSHS, Jason Dehn, MPH, CHTC, César O Freytes, MD, Hillard M. Lazarus, MD, Charles F. LeMaistre, MD, Paulette Mehta, MD, MPH, David Szwajcer, MD, FRCPC, Steven Joffe, MD, MPH, Navneet S. Majhail, MD, MS

Blood (2013) 122 (21): 554.

https://doi.org/10.1182/blood.V122.21.554.554

Published: 2013

Journal Articles

Higher Incidence of Chronic Myeloid Leukemia (CML) Among Blacks Compared to Whites in the Post-Imatinib Period (2002–2009) Corresponds with Worse Survival Observed within the Surveillance, Epidemiology and End Results 18 Registries

Adam Mendizabal, MS, Paul H Levine, MD

Blood (2012) 120 (21): 3773.

https://doi.org/10.1182/blood.V120.21.3773.3773

Published: 2012

NARROW

Clinical Outcomes and Healthcare Utilization in Patients with Sickle Cell Disease: A Nationwide Cohort Study of Medicaid Beneficiaries

Incidence and Survival of Multiple Myeloma; A Population-Based Study on 10 961 Patients Diagnosed 1982-2017

The Impact of Age on the Outcome of Primary Treatment for Classical Hodgkin's Lymphoma: 70 Years of Age Is a Clinical Relevant Cutpoint and the Most Important Predictor of Overall Survival

The Conundrum of Hydroxyurea Use and Health Care Utilization in Sickle Cell Disease

Analysis of Genetic Abnormalities in Newly Diagnosed Acute Lymphoblastic Leukemia Patients at King Faisal Specialist Hospital & Research Centre

Opioid Use Is NOT Associated with in-Hospital Mortality Among Patients with Sickle CELL Disease in the United States: Findings from the National Inpatient Sample

Patient-Reported Disease Burden in the Elderly Patients with Acute Myeloid Leukemia

Factors Predicting Poor Outcomes for Myeloma Patients at Different Ages: Results from 3894 Patients in the Myeloma XI Trial

Persistent Racial/Ethnic Disparities in Outcomes for Multiple Myeloma: A SEER-Database Update

Social Outcomes after High Dose Chemotherapy with Autologous Stem Cell Transplant

Timing of Initiation of Defibrotide Post-Diagnosis of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Post-Hematopoietic Stem Cell Transplantation: Exploratory Age-Group Analysis from an Expanded Access Study

Presentation and Time to Treatment of Atypical Hemolytic Uremic Syndrome Is Influenced By Complement Amplifying Conditions: A Single Center Experience

Mini-Chromosome Maintenance (MCM) DNA Helicase Genes Influence Acute Myeloid Leukemia (AML) Replication and Response to Chemotherapy-Induced DNA Damage

Safety of Peripheral Hematopoietic Stem Cell Mobilization with Lenograstim in Allogeneic Healthy Donors ≥ 50 Years Old: A Single-Centre Experience

Age Related Outcomes for Multiple Myeloma Patients Following Autologous Transplantation

Influence Of Age On The Efficacy and Safety Of Dabigatran Versus Warfarin For The Treatment Of Acute Venous Thromboembolism: A Pooled Analysis Of RE-Cover and RE-Cover II

Initial Characteristics, Treatment and Prognosis Of Elderly (≥ 70 years) Patients With Chronic Lymphocytic Leukemia (CLL): An Analysis Of a Series Of 367 Cases

Phase II Clinical and Correlative Study Of Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Extended Dosing (CRD-R) Induces High Rates Of MRD Negativity In Newly Diagnosed Multiple Myeloma (MM) Patients

Survival Improvements Following Myeloablative Allogeneic Hematopoietic Cell Transplantation For Acute Lymphoblastic Leukemia In Adolescents and Young Adults Have Been Comparable To Younger Children: A Study From The Cibmtr

Higher Incidence of Chronic Myeloid Leukemia (CML) Among Blacks Compared to Whites in the Post-Imatinib Period (2002–2009) Corresponds with Worse Survival Observed within the Surveillance, Epidemiology and End Results 18 Registries

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only